Patent-related actions taken in WTO members in response to the COVID-19 pandemic
Xiaoping Wu and
Bassam Peter Khazin
No ERSD-2020-12, WTO Staff Working Papers from World Trade Organization (WTO), Economic Research and Statistics Division
Abstract:
COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since then, the issue of the relationship between patent protection and the development of and access to medical treatments and technologies - a longstanding and enduringly important public policy issue - has become central to the debate on the linkages between IP, innovation, access, and public health between stakeholders with divergent interests. This working paper provides an overview of the patent landscape of medical treatments and technologies related to COVID-19, and of the patent status of two investigational medical treatments: remdesivir and lopinavir/ritonavir. It then presents various patent-related actions taken by legislators, policymakers, industry sectors, and civil society organizations in WTO Members since the outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members' national implementation and utilization of these options in their response to the COVID-19 pandemic.
Keywords: COVID-19 pandemic; patent; open innovation; patentable subject matter; repurposed medicines; exceptions and limitations; licences; government use; transition periods; LDCs; WTO; TRIPS (search for similar items in EconPapers)
JEL-codes: I18 K11 K15 K30 O30 O31 O34 (search for similar items in EconPapers)
Date: 2020
New Economics Papers: this item is included in nep-hea, nep-ino, nep-ipr and nep-law
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.econstor.eu/bitstream/10419/226168/1/1737433869.pdf (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:zbw:wtowps:ersd202012
DOI: 10.30875/fb500072-en
Access Statistics for this paper
More papers in WTO Staff Working Papers from World Trade Organization (WTO), Economic Research and Statistics Division Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().